Comparative pharmacokinetic interactions of Quercetin and Rutin in rats after oral administration of European patented formulation containing Hipphophae rhamnoides and Co-administration of Quercetin and Rutin

被引:22
|
作者
Kammalla, Ananth Kumar [1 ]
Ramasamy, Mohan Kumar [1 ]
Chintala, Jyothi [1 ]
Dubey, Govind Prasad [2 ]
Agrawal, Aruna [3 ]
Kaliappan, Ilango [1 ,4 ]
机构
[1] SRM Univ, Interdisciplinary Sch Indian Syst Med, Kattankulathur 603203, Tamil Nadu, India
[2] Banaras Hindu Univ, Inst Med Sci, Natl Facil Tribal & Herbal Med, Varanasi 221005, Uttar Pradesh, India
[3] Banaras Hindu Univ, Inst Med Sci, Fac Ayurveda, Varanasi 221005, Uttar Pradesh, India
[4] SRM Univ, Dept Pharmaceut Chem, SRM Coll Pharm, Kattankulathur 603203, Tamil Nadu, India
关键词
Drug interaction; Pharmacokinetics; Quercetin; Rutin; Polyherbal formulation; BIOAVAILABILITY; METABOLITES; GLYCOSIDES; PLASMA;
D O I
10.1007/s13318-014-0206-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Quercetin and Rutin are most common flavone constituents of some herb extracts such as Hippophae rhamnoides L. Inter and intra herb pharmacokinetics interactions of Quercetin and Rutin were investigated in the present study. Pharmacokinetic study was investigated in the two groups of rats (n = 6) for pharmacokinetic interactions between the Quercetin and Rutin (2.5 mg/kg) mixture treated alone with European patented polyherbal formulation containing equivalent weight of the above. The total plasma concentrations of Quercetin and Rutin were determined by liquid chromatography mass spectrometry (LC-MS). A method was developed and validated according to the ICH guidelines. The results of the present study shows that there are great differences in the pharmacokinetics of Quercetin and Rutin when they are administered together and from the polyherbal formulation which will be interacted by many other constituents. The bioavailability of Quercetin was lowered from the polyherbal formulation when compared with the co-administration, whereas the Rutin bioavailability has increased from the polyherbal formulation when compared with the co-administration. The maximum plasma concentration of Quercetin from coadministration and polyherbal formulation was 165.3 +/- A 31.9 and 90.8 +/- A 21.4 ng/mL, respectively, whereas in the case of Rutin it was 61.1 +/- A 29.3 and 121.7 +/- A 19.2 ng/mL. After polyherbal formulation administration to rats the AUC(0-24), AUC(0-a) and AUMC(0-a) of both Quercetin and Rutin significantly increased when compared to co-administration. The above results proved that inter and intra herb pharmacokinetic interactions between Quercetin and Rutin. Possible interactions of the other constituents with hydrolyzing enzymes in the formulation enhances the oral bioavailability of Rutin. Accordingly besides the drug herb interactions, inter and intra herb interaction might be brought into view with the wide use of herbal remedies.
引用
收藏
页码:277 / 284
页数:8
相关论文
共 14 条
  • [1] Comparative pharmacokinetic interactions of Quercetin and Rutin in rats after oral administration of European patented formulation containing Hipphophae rhamnoides and Co-administration of Quercetin and Rutin
    Ananth Kumar Kammalla
    Mohan Kumar Ramasamy
    Jyothi Chintala
    Govind Prasad Dubey
    Aruna Agrawal
    Ilango Kaliappan
    European Journal of Drug Metabolism and Pharmacokinetics, 2015, 40 : 277 - 284
  • [2] Pharmacokinetic study of rutin and quercetin in rats after oral administration of total flavones of mulberry leaf extract
    Ou-yang, Zhen
    Cao, Xu
    Wei, Yuan
    Zhang, Wei-Wan-Qi
    Zhao, Ming
    Duan, Jin-ao
    REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, 2013, 23 (05): : 776 - 782
  • [3] Bioavailability of the flavonol quercetin in neonatal calves after oral administration of quercetin aglycone or rutin
    Maciej, J.
    Schaeff, C. T.
    Kanitz, E.
    Tuchscherer, A.
    Bruckmaier, R. M.
    Wolffram, S.
    Hammon, H. M.
    JOURNAL OF DAIRY SCIENCE, 2015, 98 (06) : 3906 - 3917
  • [4] Comparative Pharmacokinetic Study of Mangiferin After Oral Administration of Pure Mangiferin and US Patented Polyherbal Formulation to Rats
    Ananth Kumar Kammalla
    Mohan Kumar Ramasamy
    Jyothi Inampudi
    Govind Prasad Dubey
    Aruna Agrawal
    Ilango Kaliappan
    AAPS PharmSciTech, 2015, 16 : 250 - 258
  • [5] Comparative Pharmacokinetic Study of Mangiferin After Oral Administration of Pure Mangiferin and US Patented Polyherbal Formulation to Rats
    Kammalla, Ananth Kumar
    Ramasamy, Mohan Kumar
    Inampudi, Jyothi
    Dubey, Govind Prasad
    Agrawal, Aruna
    Kaliappan, Ilango
    AAPS PHARMSCITECH, 2015, 16 (02): : 250 - 258
  • [6] Oral co-administration of α-lipoic acid, quercetin and captopril prevents gallium arsenide toxicity in rats
    Bhatt, Kapil
    Flora, S. J. S.
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2009, 28 (01) : 140 - 146
  • [7] Effect of co-administration of gallic acid and quercetin or gallic acid and rutin on impaired spermatogenesis and oxidative damage in a busulfan-treated rat model
    Ezim, Ogechukwu E.
    Nebeolisa, Chisom E.
    Emeagwali-John, Ifeoma G.
    Obinna, Victoria C.
    Abarikwu, Sunny O.
    DRUG AND CHEMICAL TOXICOLOGY, 2024,
  • [8] Metal ion-oxytetracycline pharmacokinetic interactions after oral co-administration in broiler chickens
    Ziolkowski, H.
    Jasiecka, A.
    Zuska-Prot, M.
    Przybysz, J.
    Grabowski, T.
    Jaroszewski, J. J.
    POULTRY SCIENCE, 2016, 95 (08) : 1927 - 1933
  • [9] 2-Deoxyglucose and hydroxychloroquine HPLC-MS-MS analytical methods and pharmacokinetic interactions after oral co-administration in male rats
    Sun, Dongxiao
    Kim, Sangyub
    Karelia, Deepkamal
    Deng, Yibin
    Jiang, Cheng
    Lu, Junxuan
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2024, 12 (01):
  • [10] COMPARATIVE PHARMACOKINETIC AND BIOAVAILABILITY STUDIES OF MONOTROPEIN, KAEMPFEROL 3-O-GLUCOSIDE AND QUERCETIN 4'-O-GLUCOSIDE AFTER ORAL AND INTRAVENEOUS ADMINISTRATION OF MOTILIPERM IN RATS
    Choi, B-R
    Karna, K. K.
    Shin, Y-S
    Lee, S-W
    Kim, C-Y
    Kim, H-K
    Park, J-K
    JOURNAL OF SEXUAL MEDICINE, 2019, 16 (05): : S53 - S54